It was once thought that paramyotonia congenita was more common in males. Observation of the most recent generation has shown this to be untrue. On average, half of children in a family inherit the disorder regardless of gender. References
Notes
Lehmann-Horn F, Rüdel R, Ricker K (1993). "Non-dystrophic myotonias and periodic paralyses. A European Neuromuscular Center Workshop held 4–6 October 1992, Ulm, Germany". Neuromuscul Disord. 3 (2): 161–8. doi:10.1016/0960-8966(93)90009-9. PMID 7689382. S2CID 20892960. Cannon S (2006). "Pathomechanisms in channelopathies of skeletal muscle and brain". Annu Rev Neurosci. 29: 387–415. doi:10.1146/annurev.neuro.29.051605.112815. PMID 16776591. Further reading
Paramyotonia congenita FAQ at the Periodic Paralysis News Desk. The site also hosts a mailing list for patients with the disorder and medical professionals interested in it. Fact page from the Muscular Dystrophy Association


== External links ==
The experimenters observed that those using the trolamine salicylate product exercised longer before reporting the  onset of soreness, reported less intense  soreness, and reported that their  soreness did not last as long as the people who used  the placebo.All of the trolamine salicylate-containing products listed in the two cited references are 10% solutions. These products are sold under various brand names, e.g. Aspercreme, and are marketed as topical analgesics for temporary relief of arthritis, simple backache, muscle strains, and sprains. See also
Methyl salicylate


== References ==